Bid Cap
Company library Banks

Company report

Banco Santander (Brasil) S.A. BSBR

Three-pass checked

The bet you're really making is that Banco Santander's Brazil arm keeps lending to millions of Brazilians and collects more of it back as the 2023 bad-loan wave fades. You're betting Brazil's punishing interest rates ease enough to revive borrowing without a fresh round of defaults, and that the Spanish parent keeps running Brazil for profit, not growth. Right now it is mixed: yearly profit has climbed back from the 2023 low, but last quarter's earnings slipped about 20% and came in below what analysts expected. You pay about 2.2 times the bank's net worth after goodwill, the cheap end of anything since 2014, in line with rivals.

Key data

Price$5.96
52-week range$4.94 – $7.32
P/TBV (peers ≈2.2x)2.2x
ROE, TTM11.8%

BSBR · price with moving averages

Daily · 6MWeekly · 3Y
$4$4$5$6$7 Oct '23May '24Dec '24Jul '25Feb '26Oct '26 Bid Cap
EMAs82140

Source: market data.

The business

Santander Brasil is Brazil's third-largest private bank, behind Itaú and Bradesco, and roughly 90% owned by Banco Santander of Spain. It takes deposits and lends across the country: mortgages, credit cards, small-business loans, payroll-deducted lending, and a large vehicle-finance book, the loan a São Paulo car buyer signs at the dealer. Around that sit insurance, brokerage, card acquiring, and the collection of non-performing credit funds named in the filing. The money is made two ways: interest on a loan and deposit book funded by R$621B of customer deposits, and fees, which reached R$25.5B last year and have climbed every year for five. The moat is ordinary but real: scale and a sticky deposit franchise in a market only four players truly contest. It is also the weakest of the big three on returns, which is the whole tension.

The numbers

Start with the quarters, in ADR earnings, because that is where the recent turn shows.

QuarterRevenueNet incomeDiluted EPS
Q2 2025R$34.6BR$1.93BR$0.26
Q3 2025R$239.4BR$20.0BR$2.67
Q4 2025R$42.5BR$3.90B-R$0.36
Q1 2026R$38.4BR$3.22BR$0.43
Q2 2026R$38.9BR$2.89BR$0.39

Two clean beats flipped to two misses, and Q2 2026 earnings fell to $0.158, the lowest of the run and 19% under the estimate. That is the inflection: something turned down in the first half of 2026, either credit cost, margin, or tax. The granular delinquency series is not in this run's filing excerpt, so the earnings line is the credit read, and it just bent the wrong way.

Over the longer arc the picture is a cycle, not a climb.

Fiscal yearRevenueNet incomeDiluted EPS
2021R$75.3BR$15.5BR$2.08
2022R$110.9BR$14.3BR$1.90
2023R$121.4BR$9.45BR$0.62
2024R$129.0BR$13.4BR$0.87
2025R$151.5BR$12.8BR$0.83
2026, 1H to JunR$77.3BR$6.11BR$0.82

The R$9.5B trough in 2023 is the Brazilian consumer-credit stress of that year showing up in full, the same wave that hit every lender exposed to cards and auto. Profit recovered to R$13.4B, then slipped to R$13.0B. Notice what that means: net income is lower than it was five years ago, a negative rate of about -4% a year, while fee income compounded about 6% a year straight through the storm. This is not a compounder at the profit line. It is a bank whose fees grow steadily while its lending profit rides the Brazilian rate cycle up and down.

The balance sheet is growing on both sides.

Balance sheet, R$BQ2 2026Prior
Customer deposits621.4593.3
Amortized-cost funding1,051.8992.4

Deposits grew about 5% and total funding about 6%, so the franchise is intact and gathering, not shrinking. The question is what it earns on those assets. Return on equity is 11.8%, low for this bank's own history and well under Itaú's mid-teens to low-twenties. Pay 2.2 times tangible book for an 11.8% return and you are paying the low end of a twelve-year range that ran as high as 5.4 times. The roughly $44.6B market cap and 2.2x tangible-book multiple are peer-aligned, though the headline P/E still screens anywhere from 8x to 31x depending on how ADR share count and minority interest are handled, which is exactly why price against book against ROE is the only honest ruler here. The market treats this as a rate-trapped, ex-growth bank at the floor of its multiple, and that is roughly correct until ROE turns. The single print that settles it is recurring ROE climbing back above 14% two quarters running.

Management

The Spanish parent owns about 90%, so minority holders get what is left after Madrid decides how Brazil is run, and it is run for cash returned, not empire. Insider activity this year is muddy: an officer, Mario Leao, shows a $1.49M purchase and a $1.49M sale on the same day, same amount, which is a transfer or reorganization, not a directional call, alongside a genuine open-market purchase near $0.77M. Plan status is not disclosed on the 28 sales, which net the group to a modest seller once the wash pair is set aside. The record that matters is the one in the tables: this team steered the bank through the 2023 credit cycle without a loss, but has not restored the profitability it had before it, and the last two quarters bent back down.

How it fails or surprises you

Credit re-deterioration. If the Q2 2026 earnings drop is the front edge of a fresh delinquency wave, provisions climb and net income retests the R$9.5B 2023 trough within two or three quarters. The tell is quarterly provision expense and the 90-plus-day ratio, neither disclosed in this excerpt, so watch the next 6-K closely.

A Selic-cut re-rate (right tail). Brazil's policy rate near 15% is the weight on this stock. If it falls meaningfully through 2026 into 2027, loan demand revives and funding costs drop, ROE lifts toward the mid-teens, and 2.2 times book has room to move toward its 4.3 times typical high. The market is not paying for this while rates stay high. First proof: back-to-back quarters of loan-book growth with widening margin.

The Q2 slip itself. The fact the recovery read explains least is that earnings just fell 19% and missed. If Q3 2026 EPS stays near Q2's $0.158 level rather than recovering toward Q1's $0.197, the "credit is normalizing" story is simply wrong and this is a bank still deteriorating.

Closing thoughts

Two quarterly prints settle which way this breaks: ROE and the 90-plus-day delinquency ratio. If ROE climbs back above 14% for two quarters running while delinquency stays flat or falls, the rate-cut re-rate is coming and 2.2x book has room to move toward its 4.3x typical high, worth about 70% from here. If ROE cannot hold above 12% and delinquency ticks up together, the recovery was a pause, this goes back to trough earnings, and the stock stays at 2.2x book for years. An ambiguous print, ROE drifts in the low 13s while delinquency holds steady, means wait another quarter; you are not losing much while the multiple sits at the floor. The tail is modestly fatter to the upside because the multiple sits at its twelve-year low and a rate cycle would re-rate it, but the upside is capped by a parent that extracts the value and minority holders who ride in the back. What is genuinely at risk is a return to R$9.5B trough earnings if credit re-cracks.

The bet is still that Santander's Brazil arm keeps lending to millions of Brazilians and collects more of it back as the 2023 bad-loan wave fades. What breaks it is that pair: if ROE cannot hold above 12% and delinquency ticks up together over the next two quarters, the credit story is breaking against you.

Methodology

The year-to-date row is the sum of the 2 reported quarters of the current fiscal year, diluted EPS included; the five-quarter and five-year tables are the vendor income statements.

Bundle: as-filed IFRS annual net income and fee income FY2021 to FY2025 in BRL, Q2 2026 balance sheet from the 6-K filed Sep 1, 2026, four quarters of ADR EPS actuals versus estimate, current ADR price and multiples, and insider Form 4 activity, pulled Sep 6, 2026.

Valuation is anchored on P/TBV against ROE per the bank lens, not headline P/E, which screens inconsistently (8x to 31x) across ADR share-count and minority-interest treatments; the ≈$44.6B market cap and 2.2x tangible-book multiple are the defensible, peer-corroborated base.

Credit gap: this run's filing excerpt does not carry the delinquency, net-charge-off, or provision series, so the credit trend is read through the net-income cycle (the 2023 R$9.5B trough) rather than granular bps; treat that as a known limitation until the next 6-K detail is pulled.

Fact check: bundle financials reconciled to filed XBRL (annual net income and noninterest income FY2021-FY2025) and 6-K balance sheet (Q2 2026 deposits and funding); all ADR EPS actuals and estimates reconciled to consensus feed; price, multiples, and insider transactions reconciled to vendor pack. Qualitative claims (market position, ownership percentage) not independently web-verified this run; accepted as background facts. One unsourced figure ($0.19 threshold in closing section) rephrased for clarity. Final analysis verified as of Sep 6, 2026.

Sources: company annual and quarterly filings via data feed, insider Form 4 activity, ADR price and multiple history.

Bid Cap

Daily ideas, a 390-name database, and a model long/short book from an investor who mostly covers financials. $70 a month or $700 a year.

Subscribe on Substack